Skip to main content

Peer Review reports

From: Telbivudine can safely reduce mother-to-child transmission in chronic hepatitis B women after 12 weeks of gestation

Original Submission
29 Mar 2018 Submitted Original manuscript
9 May 2018 Author responded Author comments - Li-Fen Han
Resubmission - Version 2
9 May 2018 Submitted Manuscript version 2
23 May 2018 Reviewed Reviewer Report - Syed Iqbal
29 May 2018 Reviewed Reviewer Report - S Saravanan
5 Jun 2018 Author responded Author comments - Li-Fen Han
Resubmission - Version 3
5 Jun 2018 Submitted Manuscript version 3
6 Jun 2018 Reviewed Reviewer Report - Syed Iqbal
29 Aug 2018 Reviewed Reviewer Report - Monique Andersson
9 Sep 2018 Author responded Author comments - Li-Fen Han
Resubmission - Version 4
9 Sep 2018 Submitted Manuscript version 4
23 Jun 2019 Author responded Author comments - Li-Fen Han
Resubmission - Version 5
23 Jun 2019 Submitted Manuscript version 5
29 Jun 2019 Author responded Author comments - Li-Fen Han
Resubmission - Version 6
29 Jun 2019 Submitted Manuscript version 6
Publishing
3 Jul 2019 Editorially accepted
12 Jul 2019 Article published 10.1186/s12879-019-4250-6

You can find further information about peer review here.

Back to article page